•
Sep 30, 2022

Stryker Q3 2022 Earnings Report

Stryker's net sales increased, driven by strong organic sales growth, but adjusted earnings were pressured by foreign currency and inflation.

Key Takeaways

Stryker reported a 7.7% increase in net sales to $4.5 billion for the third quarter of 2022. Organic net sales grew by 9.9%. Reported EPS increased 87.7% to $2.14, while adjusted EPS decreased 3.6% to $2.12. The company is taking actions to address persistent issues like foreign currency and inflation.

Net sales increased by 7.7% to $4.5 billion.

Organic net sales increased by 9.9%.

Reported EPS increased 87.7% to $2.14.

Adjusted EPS decreased 3.6% to $2.12.

Total Revenue
$4.48B
Previous year: $4.16B
+7.7%
EPS
$2.12
Previous year: $2.2
-3.6%
Organic Net Sales Growth
9.9%
Previous year: 4.5%
+120.0%
Gross Profit
$2.78B
Previous year: $2.64B
+5.3%
Cash and Equivalents
$1.42B
Previous year: $2.56B
-44.6%
Free Cash Flow
$751M
Previous year: $803M
-6.5%
Total Assets
$36B
Previous year: $34.1B
+5.4%

Stryker

Stryker

Stryker Revenue by Geographic Location

Forward Guidance

Stryker now expects full year 2022 organic net sales growth to be in the range of 8.5% to 9.0%. They expect net sales in the full year to be adversely impacted by approximately 4% and adjusted net earnings per diluted share to be adversely impacted by approximately $0.35 to $0.40. They now expect adjusted net earnings per diluted share in the range of $9.15 to $9.25 per share.

Revenue & Expenses

Visualization of income flow from segment revenue to net income